Elizabeth Davis

#sarcoma medical oncologist at VUMC, interested in clinical trials, drug development, #ayacancer, #ExerciseOncology, tweets are my own

[Elizabeth Davis @ejdavis25]

@kencardonaMD Congrats, Ken!

[Elizabeth Davis @ejdavis25]

Excited to share our multi-institutional collaboration demonstrating the safety and tolerability of INCAGN01949. @jordanberlin5 @CardinMD @VUMC_Cancer

[Journal for ImmunoTherapy of Cancer @jitcancer]

New #JITC article: First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors https://t.co/74Bd3K1qov @ejdavis25 @JaniceM10

[Elizabeth Davis @ejdavis25]

Great night to connect with the young adult cancer program @VUMC_Cancer, come join us for food and fun!

[Dr. Cathy Eng @CathyEngMD]

Friendly reminder! Please join us for the #youngadult #cancer program Fall meet and greet tonight with @DholariaMD @ejdavis25 @VonElrods 6-8PM. Great evening to meet other #thrivers and to just connect! #nashville #earlyonset #crcsm

[Elizabeth Davis @ejdavis25]

Excited to hear @MaryLauraPh talk about her amazing memoir and for discussion by @USN_PDS English Department Chair, Freya Sachs. Please join us!

[Carrington Fox @carringtonfox]

Look who’s headlining the inaugural Author Night at @USN_PDS Fall Book Frenzy… It’s @MaryLauraPh, author of Bomb Shelter and I Miss You When I Blink … Register here for Oct. 6 evening tkts: https://t.co/fr2bpcvITm

[Elizabeth Davis @ejdavis25]

Thrilled to be working with @hemoncwarner and so many others on https://t.co/1E0ISrZ9yi! @VUMC_Cancer

[Elizabeth Davis @ejdavis25]

@JTrentMDPhD @corrie_painter @RashmiChughMD @WTapMD @VUMC_Cancer

[Elizabeth Davis @ejdavis25]

Thanks to all for collaborating on this effort to better understand the effects of #COVID19 in people living with #sarcoma.

[Michael Wagner @wagsmd]

Glad to see this collaborative effort published. Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19 https://t.co/PqbxP7YP1Y #mdpicancers @Cancers_MDPI @COVID19nCCC @PGrivasMDPhD @hemoncwarner @fredhutch @SeattleCCA

[Elizabeth Davis @ejdavis25]

@jordanberlin5 @BipinSavani @CardinMD @CathyEngMD @JillGilbertMD @VKeedySarcomaMD @VUMC_Cancer @VUMCHemOnc And congratulations to @jordanberlin5 who was recognized as well!

[Elizabeth Davis @ejdavis25]

@jordanberlin5 @VUMC_Cancer @VUMCHemOnc Honored to care for these women living with #sarcoma, inspiration for ongoing research to improve the patient journey and outcomes. #ayacancer

[Dr. Cathy Eng @CathyEngMD]

Pls join us tomorrow, Wed 7/13, for our inaugural mixer for our Young Adult Cancers Program and Advisory Council at Tailgate Brewery HQ. #cancer #thrivers #patientcare #earlyonset #cancerawareness #cancersurvivor @VUMCHemOnc @VUMChealth @VUMC_Cancer @ejdavis25 @DholariaMD

[Elizabeth Davis @ejdavis25]

@PGrivasMDPhD @neerajaiims @SWOG @ASCO @myESMO @BhatiaS_MD @montypal @Huntsman_GU Congrats, Petros!

[Elizabeth Davis @ejdavis25]

Great work Dr. Wilbur, adding important data to demonstrate the importance of genetic testing for people with #sarcoma! @VKeedySarcomaMD

[Rashmi Chugh @RashmiChughMD]

Congratulations to Catherine Wilbur @Hopkins_HemOnc on an excellent presentation on pathogenic germline variants found in sarcoma pts at @UMRogelCancer and @VUMC_Cancer at #ASCO22. 48% of sarcoma pts referred had pathogenic germline variant, not just TP53...Need to refer more!

[Elizabeth Davis @ejdavis25]

Join the Vanderbilt sarcoma team as we discuss the diagnosis, treatment, and supportive measures for people living with GIST! @VUMC_Cancer @VKeedySarcomaMD

[The Life Raft Group @Liferaftgroup]

Register for Virtual GDOL Tennessee happening February 25th https://t.co/QDKKFBxEi1

[Elizabeth Davis @ejdavis25]

@patrickhu @katrinarmstrong @MGHMedicine @ColumbiaPS @kcooney1234 @dukemedicine @KimrynRathmell @VUMC_Medicine @YaleMed Equally grateful for @KimrynRathmell and @kcooney1234!!

[Elizabeth Davis @ejdavis25]

Consider a donation to our team which is focused on increasing resources and improving outcomes for young adults with cancer!

[Dr. Cathy Eng @CathyEngMD]

In honor of #WorldCancerDay PLS support:
1⃣EVENT: Inaugural spinning 🚴‍♀️ Clip in 4 the Cure
2⃣DATE: Sat 3/26/2022 8AM
3⃣GOAL: $$ #cancerreseearch @VUMC_Cancer
The ONLY NCI-Designated #Cancer Center in #Tennessee
Join us!
https://t.co/M8SuGAA2EX
@RajivAgarwalMD @ejdavis25

[Elizabeth Davis @ejdavis25]

Check out this discussion about cryoablation in desmoid tumors. This can be a great treatment option to consider, but more studies are needed to define its optimal place in the treatment algorithm. @VUMC_Cancer @NamBuiMD @dileo_palma @DTRFoundation

[Society of Surgical Oncology @SocSurgOnc]

On SurgOnc Today, @kencardonaMD, Nicholas Tawa, MD, PhD, @ejdavis25 and Marwan Moussa, MD, discuss cryoablation in the management of patients with desmoid tumors and examine clinical scenarios where treatment should be offered. Listen at https://t.co/LPWlIjupQh & Spotify.

[Elizabeth Davis @ejdavis25]

Thankful for this funding to help us continue to expand our young adult cancer program! @NashWineAuction

[Dr. Cathy Eng @CathyEngMD]

🙏@nashwineauction for✅our #grant for @VUMC_Cancer Young Adult Cancers Program (20-45 y/o) for ALL #cancer #thrivers locally and nationally! https://t.co/s2pQ1lKXyP This support is appreciated in our #patients! @VUMChealth @VUMCHemOnc @ejdavis25 + M. Byrne #CancerResearch

[Elizabeth Davis @ejdavis25]

Great work Dr. Liu under the excellent mentorship of @AngelaHirbe! Glad we could collaborate to better define outcomes in an ultra-rare sarcoma subtype. @NamBuiMD

[Jon Trent, MD, PhD @JTrentMDPhD]

Paper 76 - A MULTICENTER RETROSPECTIVE ANALYSIS ON THE EFFECT MUTATIONAL STATUS ON OUTCOMES FOR PATIENTS WITH PECOMA by Lawrence Liu @sitemancenter

Nonsignificant trend toward superior outcome with mTORi therapy for patients with PEComa

https://t.co/kSD5cieDxk #CTOS2021

[Elizabeth Davis @ejdavis25]

Further support that chemotherapy has a role in localized #sarcoma. #CTOS2021

[Jon Trent, MD, PhD @JTrentMDPhD]

Multidisciplinary Management & Neoadjuvant Therapy

Striking consensus by the multidisciplinary panel supporting Adj/neo Chemotherapy for high risk STS. Additional studies randomizing pts to no chemo would be unethical.

https://t.co/OlwBFntoer #CTOS2021 @OncoAlert

[Elizabeth Davis @ejdavis25]

@JTrentMDPhD Only hoping the discussion at @ctos2021 encourages reconsideration of and an end to the use of placebo.